Hereditary angioedema type I patients with anti-C1-INH antibodies can be effectively treated with icatibant

被引：0
|
作者：
Bouillet, L. [1 ]
Boccon-Gibod, I [1 ]
Ponard, D. [1 ]
Dumestre-Perard, C. [2 ]
Cesbron, J. [1 ]
Massot, C. [1 ]
机构：
[1] Grenoble Univ Hosp, Angioedema Natl Reference Ctr, Grenoble, France
[2] CHRU Hop Sud, Immunol Lab, Grenoble, France
来源：
ALLERGY | 2009年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
257
引用
收藏
页码：116 / 117
页数：2
相关论文
共 50 条
  • [1] An Atypical Case of Idiopathic Nonhistaminergic Angioedema With Anti-C1-INH Antibodies
    Bova, M.
    Suffritti, C.
    Joseph, K.
    Caccia, S.
    Gelderman, K. A.
    Berra, S.
    Loffredo, S.
    Santacroce, R.
    Petraroli, A.
    Roem-Haagsma, D.
    Margaglione, M.
    Spadaro, G.
    Kaplan, A. P.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2022, 32 (06)
  • [2] ANTI-C1-INH ANTIBODIES AND INCREASED CATABOLIC RATES OF C1-INHIBITOR (C1-INH) IN PATIENTS WITH RECURRENT ANGIOEDEMA
    ALSENZ, J
    BORK, K
    ROHRBORN, W
    LOOS, M
    IMMUNOBIOLOGY, 1986, 173 (2-5) : 446 - 447
  • [3] Clinical experiences with Icatibant in patients with hereditary and acquired angioedema due to C1-INH-deficiency
    Magerl, M.
    Weller, K.
    Krause, K.
    Metz, M.
    Maurer, M.
    ALLERGY, 2010, 65 : 446 - 446
  • [4] Occurrence of anti-C1q antibodies in type I hereditary angioedema
    Djenouhat, Kamel
    Gharnaouat, Merzak
    Berrimi, Douaa K.
    Naci, Dalila
    Abbadi, Mohamed Cherif
    MOLECULAR IMMUNOLOGY, 2008, 45 (16) : 4174 - 4174
  • [5] THE ICATIBANT OUTCOME SURVEY: MORE THAN 2200 ICATIBANT-TREATED ATTACKS IN PATIENTS WITH TYPE I OR II HEREDITARY ANGIOEDEMA
    Maurer, Marcus
    Caballero, Teresa
    Aberer, Werner
    Zanichelli, Andrea
    Bouillet, Laurence
    Fabien, Vincent
    Naser, Nadim
    Longhurst, Hilary
    INTERNAL MEDICINE JOURNAL, 2015, 45 : 22 - 22
  • [6] The Icatibant Outcome Survey: More Than 1500 Icatibant-Treated Attacks in Patients with Type I or II Hereditary Angioedema
    Maurer, Marcus
    Caballero, Teresa
    Aberer, Werner
    Zanichelli, Andrea
    Bouillet, Laurence
    Fabien, Vincent
    Longhurst, Hilary
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (02) : AB194 - AB194
  • [7] The icatibant outcome survey: more than 2900 icatibant-treated attacks in patients with type I or II hereditary angioedema
    Maurer, M.
    Caballero, T.
    Aberer, W.
    Zanichelli, A.
    Bouillet, L.
    Fabien, V
    Andresen, I
    Longhurst, H. J.
    ALLERGY, 2016, 71 : 242 - 242
  • [8] Icatibant use in Brazilian patients with hereditary angioedema (HAE) type 1 or 2 and HAE with normal C1-INH levels: findings from the Icatibant Outcome Survey Registry Study
    Grumach, Anete S.
    Henriques, Marina T.
    Bardou, Maine L. D.
    Pontarolli, Daniele A.
    Botha, Jaco
    Correa, Mariangela
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2022, 97 (04) : 448 - 457
  • [9] Hereditary Angioedema with Normal C1-INH (HAE Type III)
    Riedl, Marc A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2013, 1 (05): : 427 - 432
  • [10] ACQUIRED C1 INHIBITOR (C1-INH) DEFICIENCY TYPE-II - REPLACEMENT THERAPY WITH C1-INH AND ANALYSIS OF PATIENTS C1-INH AND ANTI-C1-INH AUTOANTIBODIES
    ALSENZ, J
    LAMBRIS, JD
    BORK, K
    LOOS, M
    JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (06): : 1794 - 1799
12345